Quantcast

Latest Biosimilar Stories

2014-11-11 16:23:45

Surveyed German Nephrologists Report that the Majority of Their Patients Treated with Epoetin Alfa Receive a Biosimilar, According to Findings from Decision Resources Group BURLINGTON, Mass.,

2014-11-04 12:28:43

Novel Therapies Demonstrating Evidence of Superior Head-to-Head Efficacy Will Expand the Role of Adjunct Therapy, According to Findings from Decision Resources Group BURLINGTON, Mass., Nov.

2014-10-29 16:28:36

Payers Employ a Variety of Cost-Control Measures to Manage the Utilization of Premium-Priced RA Agents, According to Findings from Decision Resources Group BURLINGTON, Mass., Oct.

2014-10-27 23:10:29

FDA has published a newlist of licensed biological products and interchangeable biosimilars, the “Purple Book”, which is being hyped as being the biological equivalent of the pharmaceutical

2014-10-22 20:23:26

Launches discussion about the future of biosimilars in Italy ROME, Oct.

2014-10-18 23:00:29

North America is the largest contributor to the global market while Asia is expected to grow at the highest rate.

2014-10-15 16:30:17

Introduces Chairman Gewanter, shows support for BQ proposal GENEVA, Oct.

2014-10-15 12:27:27

A Substantial Need Remains for Emerging SLE Biologics That Can Prevent Acute Flares and That Treat Severe Manifestations, According to Findings from Decision Resources Group BURLINGTON, Mass.,


Word of the Day
definiens
  • The word or words serving to define another word or expression, as in a dictionary entry.
The word 'definiens' comes from the Latin word 'definire', 'to define'.
Related